A unique spontaneously immortalised cell line from pig with enhanced adipogenic capacity
Thrower T., Riley SE., Lee S., Esteves CL., Donadeu FX.
Laboratory Study, published in NPJ Sci Food (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- NPJ Sci Food (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40254637
- PMCID
- PMC12010005
- DOI
- 10.1038/s41538-025-00413-y
- Citations
- 5
Abstract (original English)
Cultivated meat promises to address some of the pressing challenges associated with large-scale production of animals for food. An important limitation to realising such promise is the lack of readily available cell lines that can be expanded robustly for scale-up culture while maintaining the capacity to differentiate into tissues of interest, namely fat and muscle. Here, we report a porcine mesenchymal stem cell line (FaTTy) which, uniquely, upon spontaneously immortalisation acquired enhanced adipogenic efficiency, close to 100%, that has now been maintained for over 200 population doublings. FaTTy is able to differentiate with high efficiency in both 2D and 3D contexts and produces mature adipocytes upon prolonged differentiation. Moreover, FaTTy adipocytes display fatty acid profiles largely similar to native pig fat but with higher monounsaturated-to-saturated ratios. FaTTy displays minor aneuploidy, characterised by lack of Y chromosome, and lacks typical genetic or functional properties of tumorigenic cells. These highly distinctive characteristics, together with its non-genetically modified nature, make FaTTy a very attractive, potentially game-changing resource for food manufacturing, and particularly cultivated meat.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.